MAG
CVS icon

Mayfair Advisory Group’s CVS Health CVS Stock Holding History

Mayfair Advisory Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,785
Closed -$208K – 128
2023
Q1 		$208K Buy
+2,785
New +$234K 0.23% 109
2022
Q4 		– Sell
-2,494
Closed -$244K – 117
2022
Q3 		$244K Buy
+2,494
New +$247K 0.34% 86

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Mayfair Advisory Group's CVS Position: Q2 2023 in Review

Mayfair Advisory Group sold out of CVS Health (CVS) in Q2 2023, closing a stake of 2,785 shares — an estimated $208K sold.

Mayfair Advisory Group first reported a position in CVS in Q3 2022 and held it in 2 quarters. The position peaked at $244K in Q3 2022. 2,203 funds tracked by Wall St. Rank hold CVS as of Q2 2023.

  • Mayfair Advisory Group reported no remaining CVS Health position as of Q2 2023 after selling out during the quarter.
  • Mayfair Advisory Group sold 2,785 CVS Health shares in Q2 2023, an estimated $208K.
  • Mayfair Advisory Group first reported a position in CVS Health in Q3 2022 and held it in 2 quarters.
  • Mayfair Advisory Group's CVS Health position peaked at $244K in Q3 2022.
  • 2,203 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.

Based on Mayfair Advisory Group's 13F filing for Q2 2023, filed 24 Jul 2023.